Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Kidney & Blood Pressure Research
|
November 8, 2011
Importance of ambulatory blood pressure monitoring in adolescent hypertension
Denes Pall, Istvan Kiss, Eva Katona
Thrombosis Research
|
March 20, 2012
Factor XIII and inflammatory cells
Zsuzsa Bagoly, Eva Katona, László Muszbek
Pflugers Archiv : European Journal of Physiology
|
March 12, 2013
Quercetin as a fluorescent probe for the ryanodine receptor activity in Jurkat cells
Irina Baran, Eva Katona, Constanta Ganea
Pathophysiology of Haemostasis and Thrombosis
|
February 5, 2005
Fibrin stabilization (factor XIII), fibrin structure and thrombosis
Zsuzsanna Bereczky, Eva Katona, László Muszbek
Orvosi Hetilap
|
September 20, 2006
[Prevention of target organ damage with modern antihypertensive agents]
Dénes Páll, Eva Katona, Mária Juhász, et al.
Thrombosis and Haemostasis
|
March 6, 2007
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis
Zoltán Vokó, Zsuzsanna Bereczky, Eva Katona, et al.
Journal of Immunological Methods
|
January 19, 2010
A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears
Zsuzsanna Z Orosz, Eva Katona, Andrea Facskó, et al.
Seminars in Thrombosis and Hemostasis
|
April 15, 2010
Factor XIII and atherothrombotic diseases
László Muszbek, Zsuzsanna Bereczky, Zsuzsa Bagoly, et al.
Orvosi Hetilap
|
February 8, 2005
[Epidemiological data of 15-18 year adolescents and the prevalence of hypertension in Debrecen. The Debrecen Hypertension Study]
Dénes Páll, Eva Katona, György Paragh, et al.
Haematologica
|
February 14, 2007
Elevated factor XIII level and the risk of myocardial infarction in women
Zsuzsanna Bereczky, Emilia Balogh, Eva Katona, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Kidney & Blood Pressure Research
|
November 8, 2011
Importance of ambulatory blood pressure monitoring in adolescent hypertension
Denes Pall, Istvan Kiss, Eva Katona
Thrombosis Research
|
March 20, 2012
Factor XIII and inflammatory cells
Zsuzsa Bagoly, Eva Katona, László Muszbek
Pflugers Archiv : European Journal of Physiology
|
March 12, 2013
Quercetin as a fluorescent probe for the ryanodine receptor activity in Jurkat cells
Irina Baran, Eva Katona, Constanta Ganea
Pathophysiology of Haemostasis and Thrombosis
|
February 5, 2005
Fibrin stabilization (factor XIII), fibrin structure and thrombosis
Zsuzsanna Bereczky, Eva Katona, László Muszbek
Orvosi Hetilap
|
September 20, 2006
[Prevention of target organ damage with modern antihypertensive agents]
Dénes Páll, Eva Katona, Mária Juhász, et al.
Thrombosis and Haemostasis
|
March 6, 2007
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis
Zoltán Vokó, Zsuzsanna Bereczky, Eva Katona, et al.
Journal of Immunological Methods
|
January 19, 2010
A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears
Zsuzsanna Z Orosz, Eva Katona, Andrea Facskó, et al.
Seminars in Thrombosis and Hemostasis
|
April 15, 2010
Factor XIII and atherothrombotic diseases
László Muszbek, Zsuzsanna Bereczky, Zsuzsa Bagoly, et al.
Orvosi Hetilap
|
February 8, 2005
[Epidemiological data of 15-18 year adolescents and the prevalence of hypertension in Debrecen. The Debrecen Hypertension Study]
Dénes Páll, Eva Katona, György Paragh, et al.
Haematologica
|
February 14, 2007
Elevated factor XIII level and the risk of myocardial infarction in women
Zsuzsanna Bereczky, Emilia Balogh, Eva Katona, et al.
Page
of 5